Bridge enhanced ACL repair by Parrelli, Allan
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2020




SCHOOL OF MEDICINE 
Thesis 
BRIDGE ENHANCED ACL REPAIR 
by 
ALLAN PARRELLI 
B.S., Emmanuel College, 2014
Submitted in partial fulfillment of the 
requirements for the degree of 

































First Reader   
     Mark J. Lemos, MD 
     Vice Chair and Director of Sports Medicine Division of Orthopaedic   
     Surgery, LHMC 
 
 
Second Reader   
 John Weinstein, Ph.D. 











Thank you to my family, my friends and my classmates. 
v	
BRIDGE ENHANCED ACL REPAIR
ALLAN PARRELLI
ABSTRACT 
The mainstay of treatment for injuries to the anterior cruciate ligament (ACL) is with a 
tendon graft harvested from elsewhere in the knee. This procedure, known as ACL 
reconstruction (ACLR), has excellent reported outcomes in terms of restoring the gross 
stability of the knee. However there are reported rates of graft failure in the pediatric 
population.1 ACL reconstruction also does not provide full protection from developing 
premature osteoarthritis, which is often seen in patients after ACL injury. A new method 
must be found in order to find a solution to these adverse outcomes from the current 
standard treatment of ACL injuries. The Bridge-enhanced anterior cruciate ligament 
repair (BEAR) technique is a new innovation on primary repair of a torn ACL. It avoids 
the requirement for autograft harvesting and use of an allograft by combining a primary 
suture repair with an extraceullular matrix scaffold (the BEAR scaffold). This scaffold is 
placed between the two torn ends of the ACL to help facilitate natural healing of the 
ligament in order to restore the intrinsic functions of the ACL to protect the knee from 
trauma and instability. This ability to repair the native ACL maintains the proper anatomy 
of its insertion points, avoids donor site morbidity, and helps to prevent early 
osteoarthritis by maintaining innate proprioceptive functions of the ACL. Our study will 
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 The anterior cruciate ligament (ACL) is one of the most common injured 
ligaments of the knee joint. The exact incidence is not fully known, however, the rate of 
ACL surgeries in the age group of 16 to 39-years old is estimated at about 85 surgeries 
per 100,000 citizens.4 According to a recent study, the incidence of ACL tears in 
pediatric patients has increased over the last 20 year with females being at a higher risk.1 
This increase in incidence is likely multifactorial, including increased participation in 
organized sports, increased intensity in sports training at younger ages and greater rate of 
diagnosis.2 Peak incidence is noted during the years associated with puberty.3 Although 
only about 3% of injuries suffered in college sports are attributable to ACL injuries, they 
account for 88% of injuries resulting in greater than 10 days of time lost from sports 
participation.5 With increased awareness and incidence, parents and coaches are 
interested in ways to avoid these injuries in their children and, when it does occur, 
parents want the best possible care they can provide.  
 Currently in younger populations the hamstring autograft or bone-patellar tendon 
bone autograft (BPTB) are the “gold standard” techniques for repair -- older patients are 
more likely to receive an allograft – however, the choice is usually patient and surgeon 
specific dependent on preference and training.  An intact ACL is important for stability 
and is also needed to prevent life-long damage to the articular cartilage of the knee, 
which can result in degenerative arthritis later in life. Therefore, proper and near 
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physiologic repair/reconstruction of the ACL is paramount to prevent short and long-term 
adverse events. 
	
Statement of the Problem 
 ACL reconstruction (ACLR) failures can result from graft malposition, 
inadequate graft fixation, failure of graft incorporation, unrecognized/untreated 
associated ligamentous injuries, osseous malalignment, meniscal deficiency, and 
recurrent trauma.1 Due to concerns of donor-site morbidity, loss of innate proprioceptive 
function and traumatic articular cartilage damage, the Bridge Enhanced ACL Repair 
(BEAR) technique has been pursued to dampen all of these potential outcomes.  Primary 
repair of ACL injuries had yielded high failure rates up to 50% post-operatively until 
reconstruction techniques were implemented with tendon grafts. Primary repair has had 
some reported success in older populations, however these studies were completed in a 
population where nonoperative treatment was deemed to be just as effective.1 The BEAR 
technique is designed for a specific population of active patient at greatest risk for injury, 
recurrent injury and ACL graft failure in order to help them attain their pre-injury state 








Patients treated with BEAR technique will have superior outcomes in terms of hamstring 
strength to the modern gold-standard hamstring tendon graft 3 months post-operatively.  
Objectives and specific aims 
The objective of this study is to compare modern gold standard reconstruction of ACL 
tears to the novel BEAR technique.  This study specifically aims to: 
• Compare postoperative hamstring strength between the two techniques at 3 
months 
• Compare the risks of adverse events between the two techniques 
• Assure intact ACL’s based on Magnetic Resonance Imaging (MRI) and physical 




REVIEW OF THE LITERATURE 
 The knee joint is an important areas of articulation connecting the thigh to the 
lower leg through two joints, the patellofemoral and tibiofemoral. It is the largest joint in 
the human body acting as a hinge that allows range of motion from 0 degrees at full 
extension to around 140-150 degrees in flexion with little internal and external rotation 
allowed. The four major ligaments of the knee help to keep it stable, two of which exist 
outside of the joint while the other two exist within the knee joint. Of great importance 
and also susceptibility to injury is the ACL, which functions to prevent the tibia from 
moving too far anteriorly with respect to the femur.  Injury to this ligament is usually 
caused by non-contact lateral flexion of the knee by the action of cutting, landing 
awkwardly with some contact injuries resulting in anterior cruciate ligament ACL 
tear/rupture. 6 
	
Anatomy of the knee 
 The biceps femoris, semitendinosus, and semimembranosus are the main flexor 
muscles comprising the hamstring. The extensors of the knee consist of the quadriceps 
muscles: rectus femoris, vastus lateralis, vastus medialis, and vastus intermedius. These 
muscle groups are a common area to strengthen in order to avoid injury to the ACL or 
recovering from one.8 By doing so, less stress is placed on the ligaments of the knee, 




 On either side of the knee joint are the medial collateral ligament (MCL) and 
lateral collateral ligament (LCL) that help prevent valgus (bowing alignment) and varus 
(inward alignment) of the knee respectively (figure 1).9 These ligaments are more likely 
to be injured due to contact to the lateral side of the knee as compared to non-contact 
injuries associated with ACL injuries.1 The MCL is a commonly injured ligament of the 
knee as well, most notably caused by valgus stress with concomitant flexion and external 
rotation of the knee joint.10 This mixture of uncoordinated movements frequently causes 
MCLs and ACLs to be injured simultaneously, however, unlike the ACL the MCL shows 
admirable healing abilities in animals and clinical studies.10  
 The ACL and posterior cruciate ligament (PCL) twist around each other as flexion 
of the knee occurs, giving them their cruciate name. latin.7 These two ligaments exist 
within the knee joint with the ACL being injured at a much higher rate than the PCL. In 
fact, when it comes to knee injuries, it is much less common to injure your PCL with 
most of these injuries occurring due to traffic accidents (45%) and athletic injuries 
(40%).11 The most common mechanism of injury is due to the thigh hitting the dashboard 
during a traffic accident (the so called “dashboard injury”) or a fall with the knee flexed 









Anatomy of the Knee joint.1 
	
	
Anatomy of the ACL 
 The ACL insertion site on the femur is located at the medial surface of the lateral 
femoral condyle posteriorly in the intercondylar notch. The anterior side of this 
attachment is straight and the posterior side has a convex shape. The ligament runs 
anteriorly, distally and medially into its tibial insertion. From the femur to the tibia the 
fibers of the ligament show slight external rotation. On average, its length is 38 mm and 
the average width is 11 mm. At about 10 mm from the femoral attachment, the ligament 
fans out as it travels distally to its insertion point on the tibia. The tibial attachment is 
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oriented in an oblique direction and is wider than the femoral attachment.1 The ACL is 
made up of two different anatomical bundles. They are appropriately named the 
anteromedial (AM) and the posterolateral (PL) bundle based on their location.13 This 
classification is based on their tibial insertion achieved by the varying orientation and 
tensioning patterns of the fibers during knee range of motion.14  
 During purposeful range of motion of the knee, the ACL acts mostly to restrain 
unnecessary anterior tibial translation and some studies have found it is important in 
resisting rotational forces about the knee joint. 13 
	
Mechanism of ACL Injury 
 The mechanism of an individual ACL injury is often unknown with most injuries 
occurring due to a non-contact twisting mechanism (around 70%).16 Information is 
mostly based on a thorough patient history recalling the moment of injury, as well as 
family members or friends who may have witnessed the injury. 16 
 Video analysis of ACL injuries has found a common mechanism of injury deemed 
“dynamic knee valgus.” The common, non-contact situation frequently seen and analyzed 
finds the hip internally rotated, the knee in close to full extension with a planted foot in a 
full body deceleration, resulting in apparent valgus collapse. The ACL injury is usually 
observed when the body’s center of mass is behind and away from the area of foot-to-
ground contact.11 If the knee is forced into axial compression, the lateral femoral condyle 
is subject to posterior subluxation down the slope of the tibial plateau. The ensuing 
anterior tibial translation and internal rotation puts the ACL in substantial stress that is 
	
8 
usually too much to handle.1(p1) The forcing of the femur anteriorly compared to the tibia 
is the motion the ACL attempts to resist bringing it to the point of injury.  
 As of now, it appears that the motion being performed leading to the injury has 
more influence on the likelihood of non-contact ACL injury than inherent fixed 
(nonmalleable) risk factors. A history that may clue into a potential ACL tear include a 
non-contact mechanism of injury, hearing a "pop" at the time of injury, early swelling 
caused by rupture of the vascular ACL, and failure resume physical activity after the 
injury.1 Collateral ligament tears are less likely to result in swelling and commonly 
patients with partial posterior ligament tears (PCL) can resume play. Delayed swelling 
the following day more commonly occurs the next day in meniscal injuries.  
 In describing a tear injury of a ligament, the grade of the tear is an important 
aspect to determine the next steps for the patient.  Grade I injury to the ligament indicates 
mild damage with the ligament being slightly stretched but still retaining its ability to 
help keep the knee joint stable. Grade 2 injuries to the ligament are referred to as a partial 
tear, which causes the ligament to be loose. Lastly, a Grade 3 tear is usually called a 
complete tear where the ligament is split into two pieces and the knee joint becomes 
unstable and will result in severe pain.1  
	
Evaluation of Potential Injury 
 Medical evaluation and detection of an ACL injury begins with a history and 
physical exam. Patients with ACL injuries will most likely present to an athletic trainer, 
Emergency Room  health care professional, Primary Care Physician (PCP), or a physical 
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therapist after an injury to their knee.  It’s important to note the important criteria of the 
patient history and physical exam (PE) when they present with a potential ACL tear.  
 The most common test performed during the physical exam to assess for ACL 
injury is the anterior drawer test. With the patient in supine position, hips are flexed to 45 
degrees and knees flexed to 90 degrees. The examiner will grasp the tibia of the injured 
leg just below the knee upon the tibial and femoral joint line and draw it forward while 
resting their leg on top of the patients foot.  A positive test is defined as the tibia moving 
farther anteriorly than that seen on the uninjured knee or if the endpoint seems to be 
softened or absent.  
 The Lachman test is completed with the patient in supine position with the injured 
flexed at 20 to 30 degrees. The examiner will hold the patients thigh with one hand and 
place the other hand under the tibia with the thumb again on the joint line. As the tibia is 
pulled forward a firm resistance suggests an uninjured knee, while free movement 
without a hard endpoint indicates ACL injury. The quantity of the translation must 
always be compared with that of the unaffected knee with the quality of the endpoint 
being described as either “firm/sudden” or “absent/soft”.  
 When it comes to sensitivity and specificity, a meta-analysis found that the 
Lachman test was superior in both categories at 68% and 96% while the anterior drawer 
test was 38% and 81%.1 However, the Lachman test has proven more difficult to perform 
accurately due to patients’ inability to relax the upper leg musculature and examiners 
with smaller hands having some difficulties performing it.1 
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 Another maneuver commonly used is the pivot shift test; with the patient in 
supine and knee extended and hip flexed at 30 degrees. With one hand, the examiner puts 
the lower leg into internal rotation via the heel and with the other applies valgus stress 
while bringing the knee into flexion. A positive test is confirmed by anterior tibial 
subluxation on the distal femur at around 30 degrees, and if positive the proximal tibia 
will clunk back into place while returning into extension. Pain and guarding, however, 
can make this examination difficult on patients.1 
 The importance of accuracy in performing these PE tests is critical to guiding the 
next steps for the patient when it comes to diagnosing an ACL injury. 
	
Risk Factors for ACL injury 
 There are some unavoidable intrinsic factors that increase risk for ACL injury, 
mostly related to anatomy. Both the concavity depth of the medial plateau and the degree 
of posterior-inferior tibial slope alters people’s risk for non-contact ACL injuries.1 Joint 
laxity has been identified as a risk factor as it affects not only sagittal knee motion 
(hyperextension) but also coronal knee motion (valgus), which can stress the ACL and be 
related to increased risks in athletes.1 
 Puberty and growth spurts are suggested risk factors, which is likely attributed to 
rapid gains in body weight, height, and bone length as the two longest levers in the 
human body (the femur and tibia) likely exert greater torque upon the knee when in 
motion.1 A higher body mass index (BMI) is also associated with greater joint force, 
making it more difficult to maintain balance and dampen this force throughout high 
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velocity movements. Testosterone in pubertal boys has been found to help mediate 
muscular power, strength, and coordination, allowing them more neuromuscular control. 
Pubertal females don’t experience this testosterone surge and concomitant muscular 
growth, potentially leading to their increased rates of ACL injury.1  
 A new potential physiological risk factor recently studied is associated with the 
menstrual cycle. Females are more susceptible to injury, especially during the pre-
ovulatory phase, leading to the hypothesis that female hormone levels, as well as being 
post-menarche, play a role, although many deem this risk factor controversial and 
unequivocal.1 Some have found that people may have a genetic predisposition and a 
previous ACL injury also serves as a risk factor as well.1 In regards to participation in 
sports, those who were playing a collegiate sport are at an increased risk of ACL injury 
compared to high schoolers.1  
  Some modifiable risk factors are related to neuromuscular and biomechanical 
factors pertaining to core stability and increase in knee valgus, or an increase in knee 
abduction moment and angle upon landing.  It was found that strength deficits of the hip 
abductors and external rotators relative to body weight could increase the risk of injury.1 
Also, when compared to males, females have less hamstring strength predisposing them 
to injury. This was corroborated by the finding that male soccer players showed a 
decreased resistance to fatigue, which could result in an imbalance between the 




History of ACL repair 
 When surgery is the treatment for an ACL injury, the bone-patellar-bone graft 
autograft and hamstring autograft have become the “gold standard” techniques for repair. 
However, clinicians may choose differently depending on the patient and comfort with a 
specific technique.  
 The treatment of ACL injury has come a long way since its conception, from a 
simple repair by suture reapproximation to autografts/allografts, as well as synthetic 
material. This all began with the discovery of the ACL by Claudius Galen, a Greek 
physician of the Roman Empire who described it as being a support structure of the joint 
to impede abnormal knee movements. 
 The idea of the Lachman test to assess for injury to the knee was first annotated 
by a Greek named Georgios Noulis in 1875.  25 years after this Battle reported an ACL 
repair that was done two years earlier and considered to be “satisfactory” with no other 
details on the outcome or procedure. 
 Kenneth Jones believed he produced a “nearly physiological” reconstruction 
compared to other techniques with the ability to repair old injuries. Jones used the middle 
third of the patellar tendon excised lengthwise and extending proximally into the 
quadriceps tendon. With a saw, a triangular portion of the patella bone was cut from the 
superficial cortex. This created a graft that was still attached to the tibial insertion and 
allowed the patella to pass through a femoral tunnel made prior to excision of this 
autologous graft. In 1969 Franke used a completely free autologous graft from the 
patella, taking a piece of bone from both the patella as well as the proximal tibia, 
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becoming the first person to use a completely free graft in this manner. This is where the 
“gold standard” technique for ACL reconstruction originated from and became the norm 
in the 1990s. It was given the label of the Jones Procedure due to his innovative work. 
 As the Jones Procedure became more and more popular due to its simplicity and 
reproducibility some started experimenting with the idea of using allograft tissue to 
reconstruct the ACL starting in the 1980s. The hope was to minimize the surgical 
morbidity caused by autograft harvesting and also increase precision when it came to 
size, shape and mass in comparison to the patient's own ACL. Some still choose to use 
allografts with the main concerns relating to elongation of the graft as well as rupture.1 
 As even more clinicians began looking into different ways to treat ACL tears and 
maximize recovery some suggested the idea of using biological and biomechanical 
materials of pure carbon in the early 1970s. The evidence in animal models was 
optimistic so human models began receiving carbon-fibre ACL grafts in the early 1980s. 
While at first it seemed successful, subsequent operations using the carbon-fibre ACL 
grafts yielded serious complications. These grafts were found to rupture soon after 
surgery showing minimal resistance to torsional force. The ruptured synthetic ligament 
would then deposit carbon in the liver and cause inflammatory synovitis of the knee joint 
with pain also being reported by patients. 
 Around the 1980s the procedure of repairing ACLs was being done 
arthroscopically and surgeons were again becoming increasingly optimistic when it came 
to synthetic materials as a way to avoid the morbidity of autologous grafts. Gore-Tex 
ligament made from polytetraflouroethylene (PTFE) was already a part of medicine used 
	
14 
by vascular surgeons and was approved by the Food and Drug Administration (FDA) for 
patients who previously failed an autologous ACL reconstruction surgery. This PTFE 
material would be wound into loops and implemented for ACL reconstruction to be a true 
prosthesis in hopes that it could completely replace the natural ACL ligament. 
 Many patients had ruptures of the implantation, revision operations, and others 
showed PTFE particles in lymph nodes that resulted in complications at sites outside of 
the knee. This material was withdrawn from the market in 1993.1 
The Dacron ligament primarily used for acromio-clavicular joint injuries and in tendon 
reconstruction, gained approval by the FDA.  As with others the immediate results 
seemed to show potential. However, several years of follow-up saw complications begin 
with signs of degenerative osteoarthritis, higher than acceptable rupture rates, and 
unsuitable stability/functional outcome reported by patients.1 
 Similar in timing during the 1980s the Leeds-Keio ligament was produced as a 
“scaffold” type of prosthesis, acting to initiate tissue ingrowth of the ruptured ACL. up. 
This was used on a world-wide basis in over 50,000 patients for ACL reconstruction. A 
long-term follow-up of 10-16 years after the procedure found nearly a quarter of patients 
had a rupture of their ligament and showed increased degenerative changes as compared 
to the opposing healthy knee. 1 
 With all these attempts to find a better means of ACL reconstruction many 
orthopaedic surgeons began to lose faith in this idea of a synthetic replacement to avoid 
autologous/allo-grafting. The hope with synthetics was to circumvent the negatives 
associated with autologous grafting of local tenderness at the site of the graft, patellar 
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crepitus and pain/weakness of the extensor mechanism. With synthetics all of this would 
be avoided with the added bonus of convenience, abundant supply and significant 
strength.18 
	
New Trend in ACL Repair 
 However, it seems the trend in synthetic repair of ACL injuries has been 
rejuvenated with a recent boost in biotechnology and mechanics, as well as research 
pertaining to ligament recovery after injury. Over the past several years Martha Murray 
MD working at Boston Children’s Hospital has explored the use of synthetics to continue 
evaluating the possibility of avoiding autografting or allografting. Simple suture repair of 
tears has shown a failure rate of about 50-90% in the years after surgery.1 Currently the 
method of autologous grafting from elsewhere in the knee, commonly the patellar bone 
tendon bone reconstruction or hamstring, is the procedure of choice. It has great 
outcomes with adequate stability of the knee and a high rate of return to sports but also 
suffers drawbacks. Not only does the replacement ACL need to repair but the site of the 
graft needs to repair itself as well. Even with intense rehabilitation, weakness and pain 
can be seen and this is especially the case with hamstring grafts. According to Buau et al. 
only 40% of patients recover completely after ACL reconstruction and the percentage of 
normal Internal Knee Documentation Committee score in these patients was 33% and 
41%, respectively, for semitendinosus and a ligamentaum patella graft. The main adverse 
effect of autologous grafting that should try to be avoided is the high risk of post-
traumatic arthritis. Most patients (78%) will develop osteoarthritis 14 years post-op. 
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Therefore, if a teenager has an ACL reconstruction, they are likely to have osteoarthritis 
by their 30s.1 It is also important for athletes to return to their sports quickly with pain 
and instability resolving soon after operation.  
 The main concept behind Dr. Murray’s new evolution in ACL repair is based on 
the differences in the mechanisms of intrinsic repair of the MCL, as compared to the 
ACL. The site of injury for both the ACL and MCL show signs of cell proliferation along 
with extracellular matrix production and cell migration. Because the MCL exists outside 
of the knee joint, the clot formation persists and its breakdown process occurs in a much 
slower fashion over several days compared to the ACL joint.1 Urokinase plasminogen 
activator (uPA) can be found in the synovial fluid after injury and is thought to play a 
part in the dissolution of the fibrin-platelet within the joint. This enzyme causes elevated 
levels of plasmin in the joint, accelerating the dissolution of fibrin and impairing clot 
formation.1 Therefore, when an intrasynovial injury occurs, a hemarthrosis develops and 
uPA within the wound site prevents the formation of a clot to aid in healing.1  
 The first step in Dr. Murray’s research involved identifying which signals and 
cascades in healing were vital in repair and how to deliver them to the site in a sustained 
fashion to promote healing. Plasma rich protein (PRP) has been used with great success 
in the past and was found to contain all the proteins important in initiation of this healing 
cascade.1 Simple injection of PRP into the joint proved unsuccessful in several models, 
likely due to the presence of uPA within the joint. To overcome this, a new delivery 
system was devised to introduce and maintain the RPR within the wound site of the ACL 
with a collagen scaffold. This scaffold has the ability to form copolymers when mixed 
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with fibrin and also helps to avoid breakdown by plasmin.1 Another added benefit of the 
collagen scaffold Dr. Murray uses stems from its ability to activate platelets in a slow and 
continuous fashion, releasing associated factors over the course of 10-14 days rather than 
instantaneously. Used alone, collagen and platelets have been found to have no beneficial 
biomechanical outcomes in in vivo experiments.1 
 This collagen platelet scaffold has passed all biocompatibility checks and sterility 
testing for use in clinical studies. The implanted scaffold contains extracellular matrix 
proteins, including collagen, that has been obtained from bovine tissue with minimal 
DNA content (less than 50 ng/mg) measuring 22 mm in diameter by 45 mm in length and 
is made to encapsulate the frayed ends of the torn ACL providing an area for healing and 
support. When blood is added, it is absorbed into the scaffold, which softens to provide 
an added level of comfort.  In the early stages of healing, it acts as a cushion, giving the 
damaged ACL a platform to fill in irregular contouring of the torn ligament. 1 
 The potential of the BRIDGE procedure derives from its ability to preserve the 
natural anatomy of the ligament, specifically the insertion sites and the native double 
bundle physiology of the ACL. Additionally, it may maintain some of the intrinsic and 
native physiology of this joint when it comes to the cell populations and biochemical 
properties as well. Being able to maintain this intrinsic nature of the knee may ensure any 
proprioceptive function of the ACL can help protect the knee from subsequent injuries.  
 The pre-pubescent population stands to benefit from this new regenerative 
treatment. The methods behind this technique avoids interference of the potentially 
immature physes, and, as seen in recent studies, this population of patients may respond 
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with a better effect due to the addition of a biological stimulus.  By avoiding transphyseal 
drilling there is a lower risk profile associated with the procedure that will prevent 
physeal complications. By implementing a repair technique rather than a reconstruction 
native tissue and fibers are regenerated having the potential to maintain innate 
proprioceptive properties. Also, the native insertion sites on both the tibia and femur are 
maintained whereas in reconstructions a tissue of similar properties is placed via 
estimated tunnels based on the providers’ anatomic knowledge of insertion sites. This 
new method could result in a more maintenance of more physiologic biomechanics of the 
knee if sufficient regeneration is achieved.  
 
Existing research 
 One of the greatest limitations when it comes to ACL wound healing is the lack of 
viable cells that can aid in the healing process. Many researchers have looked for a way 
to circumvent this process with the addition of exogenous cells to the area of injury and 
stimulate the healing process that is seen elsewhere. Huang et al. found that a collagen 
scaffold is strengthened by fibroblasts, an important part of our innate healing process, 
and, if delivered to the injury, may induce a faster and more productive healing process in 
the ACL.43 This was taken a step further when Bellicampi et al. placed a fibroblast-
seeded collagen scaffold into rabbit knees and found them to be viable 6 weeks after 
implantation. 44 
 Bone marrow stromal cells (BMSCs) have also been studied in terms of their 
ability to enhance innate healing and Soon et. al found that reconstruction of rabbit ACLs 
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had a greater load-to-failure rate when BMSCs were added to an Achilles tendon graft 
compared to a graft without BMSCs.45 This method, however, has limitations with the 
first being the requirement of several stages: starting with the desired cells being 
harvested; expanded over a certain time increment; and then proper implantation of those 
cells after. Companies must prove safety and efficacy of cell growth with their ability to 
keep them sterile (i.e. bacteria, viral and chemical free) and also ensuring they do not 
become mixed or contaminated with another patient’s cells. Once these cells are 
implanted during the second procedure only a small percentage persist for more than a 
few weeks, likely due the rapid change in the environment of these cells.46  
 In vitro studies have suggested that epidermal growth factor (EGF), fibroblast 
growth factor (FGF), platelet-derived growth factor (PDGF) and transforming growth 
factor (TGF) improve collagen synthesis and/or cell proliferation with ligament 
fibroblasts.474849 Kobayashi et al. reported that, in canines, FGF enhanced the healing and 
neovascularization of partially lacerated ACLs.50 Letson et. al and Spindler et. al reported 
that rat ligaments increased their stiffness when PDGF was added and recombinant TGF 
increased collagen expression, as well as maximum, load when added to rabbits.4751 
However, both these studies were performed on MCLs and not ACLs. Many studies have 
found a synergistic effect of growth factors in vitro, however, these findings are usually 
not fully translatable to in vivo studies.  In vivo these endogenous growth factors are 
likely secreted over time due to a variety of signals triggered by the host cells and this has 
proven difficult to replicate. In most experimental studies these growth factors are 
delivered as a one-time dose. Sometimes these factors are delivered within a carrier to try 
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and elongate the secretion process, however, even with these modifications factors can be 
cleared within hours.52 
 Much investigation has been made into platelet-rich plasma (PRP) in terms of its 
ability to aid in the healing process of many joints and tissues and has been a point of 
interest in ACL and ACL graft healing. Nin et al. completed a randomized controlled trial 
investigating the outcomes of ACL reconstruction with an allograft alone or an allograft 
with the addition of PRP. Treatment with PRP showed no change in inflammatory 
parameters, appearance on MRI, or clinical outcomes between the two groups.53 Similar 
to this, Vogrin et al. studied the vascularization of the intra-articular portion of a PRP 
supplemented hamstring autograft via MRI. Early vascularization was not seen in the 
graft or in the interface of the bone and graft, thus suggesting that PRP alone is not 
effective at enhancing healing.  Silva et al. used MRI in a prospective study of 40 patients 
treated with ACL hamstring reconstruction with or without PRP in the graft tunnel or in 
the joint and found no difference in signal intensity at 3 months after surgery, further 
suggesting PRP alone does not augment the healing process.54  
 With inconclusive results, more information was required to determine the 
discrepancy between these in vivo results compared to results seen during the in vitro 
healing process. Harrold et al. determined that fibrinolysis is a strong factor in prevention 
of blood clotting within the joint capsule, which could be the cause of rapid instability of 
PRP, as its main protein base is found within fibrin.37 Kroon et al. attempted to overcome 
this by adding the copolymer collagen to evade the degradation caused by plasmin and 
found this combination is able to resist fibrinolysis.55 This confirmed combining PRP 
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with a collagen scaffold may be the solution to stabilizing the essential biological 
properties of PRP, as the scaffold showed protection against plasmin and its degradation 
properties. This combination has received extensive testing in large animal models with 
good effect in recent years.  
 Fleming et al. in 2009 used 13 porcine models comparing unilateral ACL 
reconstruction with a standard bone-patellar tendon-bone allograft (BPTB; n=6) to using 
collagen-platelet composite (CPC) around the BPTB allograft (n=7). Anterior posterior 
(AP) laxity values of the reconstructed knee normalized to the contralateral control 
(uninjured knee) was decreased by 28% and 57% at 60 degrees and 90 degrees of knee 
flexion, respectively, with the addition of CPC (P<0.01). The yield load and maximum 
failure load of the graft was also greater in the CPC group by ~60%. Increased 
hypercellular and hypervascular tissue was found with supplementation of the CPC at 15 
weeks. This suggests the addition of a biological scaffold during surgery could improve 
biological integration of the graft tissue. Therefore, the CPC could potentially improve 
the nutritional environment and induce cellular migration and proliferation. On histology 
cellular and vessel infiltration was found in both graft groups, however areas of necrosis 
were evident on the standard ACL-reconstruction group. The enhanced ACLR (E-ACLR) 
graft tissue showed greater vascularity when compared to the ACLR grafts; vessels were 
found to traverse into the graft material. 
 This was the first study reporting improvement in AP laxity, as well as structural 
and material properties for an ACL graft with a biological stimulus within a device. It 
was previously determined in vivo that high levels of FGF-2, PDGF-AB and TGF-β1 are 
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found near a CPC implantation for up to 3 weeks post gel implantation, suggesting a 
continued existence of these platelet-related growth factors within the wound site after 
platelets have been activated.56 This study provided evidence that autologous platelets 
from peripheral blood could be used in the same way as recombinant TFG-B1, EGF and 
PDGF, which greatly reduces costs.  
Thus, after 15 weeks the supplementation of an ACL graft with a collagen-platelet 
composite enhances the biomechanical properties of ACL allografts in a pig model by 
decreasing knee laxity while also increasing structural properties40 
 In terms of the study limitations, only one time point was selected to determine 
efficacy of the CPC enhanced compared to unenhanced model. Also, these animals were 
not randomized to a particular group as the ACLR group underwent surgery prior to the 
E-ACLR group by the same surgeon with the same instruments and protocol aside from 
the addition of the CPC, potentially adding bias. This study, however, provided initial 
findings on which further studies could expand upon by looking at different time points 
for healing.  
 Another limitation for every study using animals is the model itself, in this case 
the porcine. The porcine model is commonly used for studies pertaining to the knee joint 
due to its anatomic similarities when it comes to size equivalence compared to other 
models. The porcine also is dependent on its ACL for joint stability, has similar 
hematologic characteristics to humans and, compared to other animals, they are relatively 
easy to work with and care for. In terms of limitations, these animals have a rapid rate of 
growth, they weight bear on four limbs compared to two, and likely have many subtle 
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differences in anatomy, gait and rehabilitation. The final limitation is potential and still 
unknown differences in the wound-healing cascade between the two species.  
 
 In 2009 Murray et al tested a provisional CPC on immature pigs receiving 
repair. The goal was to show that functional healing could be improved in ACL repairs 
with the CPC based on an increase in cellularity and increase in parallel collagen bundles 
with a normal waveform. Yorkshire pigs (N=18) were used and bilateral transections of 
the mid ACL were done with one knee undergoing solely primary repair and the other 
undergoing primary repair with CPC treatment.  The healing process was then analyzed 
at 4 weeks (n=5), 6 weeks (n=4) for bilateral repair (one with and one without CPC), and 
3 months using solely unilateral repairs (n=4) and solely unilateral repair with CPC 
(n=5).  
 At 3 months of healing, the CPC-treated ligaments had significantly better 
functional measures than the ligaments treated with suture repair alone. The CPC 
ligaments had a 76% greater yield at load (P = .05), a 320% increase in linear stiffness 
(P = .015), and a 47% decrease in the displacement at yield (P = .05).  
 Based on MRI scans the minimum and maximum cross-sectional areas of the scar 
mass were determined and, at 3 months, there was no significant difference in the 
minimum cross-sectional area of the ligaments of the suture and CPC groups (39.3 ± 23.8 
and 29.8 ±13.2, respectively; P > .05) and no significant difference in the maximum 
cross-sectional area (71.3 ± 40.2 and 57.2 ± 37.7, respectively; P > .05). 
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 At 3 months, the CPC group had 25.5% higher cellularity (P = .015). Between 6 
weeks and 3 months, the suture group had shifted to a more spheroid cell shape, whereas 
the CPC group maintained a fusiform cell shape and the CPC group had a significantly 
higher proportion of fusiform cells at the 3-month time point (P < .001).57 
 This study compared the use of suture repair alone with suture repair 
supplemented with CPC. The observation that CPC improved the biomechanical function 
of the repairs at 15 weeks is interesting. Prior studies have demonstrated that the use of 
platelet-rich plasma alone or the use of a collagen scaffold alone is ineffective at 
improving the biomechanical properties of an ACL repair. This finding suggests that the 
combination of a provisional scaffolding (collagen in this experiment) and a source of 
stimulatory cytokines (as found in platelets) may be necessary to achieve enhanced 
functional healing and that the use of one component or the other alone may not be 
sufficient.57 
 Although this study did provide data concerning cellular proliferation, vascular 
proliferation, vascular pruning and early remodeling phases in a functionally healing 
ACL, it did have limitations. This study only came with 3 time points and, since 4 weeks 
was the first assessment, analysis of the acute phase of inflammation was missing, as was 
the remodeling phase that occurs after 3 months. Pigs do provide a great model for a 
study of this kind as stated in the previous study; however, they are clearly different from 
humans as quadrupeds that do not allow for post-op rehabilitation. Also, biomechanical 
testing was done before assessing cellularity and vascularity but this should not 
disproportionally affect one group over the other and it is unlikely to alter the main 
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features of each. Although more time points are necessary to help characterize enhanced 
repair, the data found in this study helped provide an impetus to continue studies on these 
enhanced repair methods as a possible solution to the problem at hand. 
 
Vavken 2012  
 In this study 24 skeletally immature pigs underwent unilateral transection and 
were randomly assigned to have either a bioenhanced ACL repair with a collagen platelet 
composite, bone-patellar tendon-bone allograft reconstruction or no further treatment 
(n=8 in each group). The goal of this assessor-blinded, randomized, active-controlled 
study was to compare the biomechanical outcomes of the new method of ACL repair with 
reconstruction in a large animal study.  
 Preoperatively, there were no differences in maximum flexion angle (P = .268), 
minimum extension angle (P = .460), or thigh circumference (P = .118) among knees 
allocated to ACL transection, ACL reconstruction, and bio-enhanced ACL repair. After 
15 weeks, bio-enhanced ACL repair and ACL reconstruction produced superior 
biomechanical outcomes to ACL transection. However, there were no significant 
differences between bio-enhanced ACL repair and ACL reconstruction for maximum 
load (P = .4745), maximum displacement (P = .4217), or linear stiffness (P = .6327). 
There were no significant differences between the 2 surgical techniques in 
anteroposterior laxity at 30° (P = .7947), 60° (P = .6270), or 90° (P = .9008).58  
Biomechanical outcomes after bioenhanced anterior cruciate ligament repair and anterior 
cruciate ligament reconstruction were equal in a porcine model. There were no 
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macroscopic signs of weight-bearing cartilage injury or meniscus damage in either the 
bio-enhanced repair or reconstruction group. Statistically, there was no significant 
difference in yield displacement (P = .225) or maximum displacement (P = .422) 
between the 2 treatment groups. Yield displacement was 98% (95% CI: 72% to 125%) of 
the contralateral intact ACL after bio-enhanced ACL repair and 85% (95% CI: 55% to 
115%) after ACL reconstruction. Maximum displacement was 84% (95% CI: 71% to 
96%) and 79% (95% CI: 52% to 107%) after repair and reconstruction, respectively 
suggesting that bioenhanced ACL repair may be superior, however this study was 
underpowered due to its small sample size. 
 This study was able to show that the structural properties of the ligament after 
bio-enhanced ACL repair were not significantly different from graft reconstruction with 
both showing improvements in AP knee laxity, ACL linear stiffness, and displacement to 
yield failure over ACL transection. Some pitfalls of this study include results only being 
seen at one time point; long-term effects can be predicted based on these findings but not 
confirmed fully without clinical data. As previously stated, animal models also do not 
completely reproduce the human. In terms of the bone-patellar tendon-bone graft, an 
allograft was used instead of an autograft (more commonly done in ACL reconstruction 
in humans) and the full patellar tendon was used rather than the middle third. This could 
have resulted in a stronger graft than what is usually seen. Also, these pigs were 
immature skeletally, a choice made specifically for this study due to an increased demand 
for an improved method of ACL injury in pediatric patients. With that being said, these 
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results may not be fully translated to adult patients but could serve as an appropriate 
repair technique without affecting the growth plate. 
 
Murray et al 2013  
 In this study 62 Yucatan mini-pigs were used in a controlled laboratory setting to 
determine the differences in tensile properties and macroscopic cartilage damage after 6 
and 12 months in three different repair techniques. The three techniques used were 
conventional ACL reconstruction, bio-enhanced ACL reconstruction, and bio-enhanced 
ACL repair all compared to an untreated ACL transection. Reconstruction and repair 
differ in that a reconstruction does not use the native torn ACL (repair) but instead using 
an auto- or allograft. Pigs were randomly placed into the 4 different groups; the 3 
repair/reconstruction techniques (n=8 for each group) and untreated transection (n=7). 
Blinded investigators tested biomechanical properties, ligament histology and 
macroscopic cartilage assessment on each group; half at the 6-month interval and the 
other half at the 12 month interval. The goal was to yield similar structural tensile 
properties in all 3 treatments groups (bio-enhanced ACL repair, bio-enhanced ACL 
reconstruction, or conventional ACL reconstruction) but superior results to the untreated 
ACL transection. The secondary hypothesis was that there will be fewer microscopic 
cartilage defects in the bio-enhanced ACL group compared to all other treatments.59 
 The first hypothesis of this study was confirmed with findings of the structural 
properties (linear stiffness, yield and maximum load) following bio-enhanced repair to 
not be significantly different from bio-enhanced reconstruction and conventional ACL 
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reconstruction. Also, all of these groups did have significantly greater structural 
properties as compared to the untreated ACL reconstruction after 12 months of healing.  
 After 12 months, the mean AP laxity values at 30° flexion for all three surgical 
treatment groups were significantly lower than the ACL transected group (padj<.0269). 
No other significant differences in AP laxity were found. Otherwise, the normalized 
linear stiffness values for the ligament or graft following bio-enhanced ACL repair, bio-
enhanced ACL reconstruction and conventional ACL reconstruction were equivalent to 
each other (padj>.5746). A similar pattern of findings was found for observed yield load 
and maximum failure load with cross sectional areas of the bio-enahnced ACL repairs 
and both grafts being highly variable and not significantly different (p>.14). (fig. 2) 
 
Figure 2: The mean differences between limbs 
 
(Surgical-Intact) for A) linear stiffness, B) yield load, and C) maximum load for the four experimental 
groups (ACLT=ACL transection, ACLR=ACL reconstruction, BE-ACLR=bio-enhanced ACL 
reconstruction and BE-Repair=bio-enhanced ACL repair) at 6 and 12 months. The mean data are plotted 
with the 95% confidence intervals. A value of zero indicates that the yield or maximum failure loads are 
equal between legs. Means that do not differ between groups after Holm adjustment within each time point 




 In terms of cartilage defects there was no significant difference in lesion area of 
the surgical limbs between the four groups at 6 months (padj>.380). However, at 12 
months the mean lesion area for the bio-enhanced ACL repair knees was significantly 
less than the ACL transected knees (padj=.0017) and the bio-enhanced ACL reconstructed 
knees (padj=.0198). Therefore from 6 to 12 months there was a trend indicating that the 
lesion areas in the bio-enhanced ACL repaired knees were less than the ACL 
reconstructed knees (padj=.068) (fig. 3). This difference in cartilage damage is potentially 
the effect of the bio-enhanced ACL repair during the time of injury due to altering joint 
inflammation with the protective quality of the articular cartilage likely being 
multifactorial. It is well known that joint kinematics negatively impact cartilage 
metabolism and reconstruction/repair is aimed at thwarting this process. Examination of 
the AP laxity in all 4 groups indicated that normal kinematics were not fully restored and, 
therefore, other factors might have had an impact on chondroprotection. This could be 
potentially due to the growth factors released by the PRP containing scaffold, a current 










Figure 3: The mean total lesion areas for the four experimental groups 
 
(ACLT = ACL transection, ACLR = ACL reconstruction, BE-ACLR = bio-enhanced ACL reconstruction 
and BE-Repair = bio-enhanced ACL repair) at 6 and 12 months for the surgical and the ACL intact knee. 
The mean data are plotted with the 95% confidence intervals. Means that are significantly different after 
Holm adjustment are highlighted with *(padj<.05) or **(padj<.01). It should be noted that it was not 
appropriate to normalize the findings to the contralateral knee as there were significant differences in the 
contralateral knee between treatment groups both at 6 and 12 months (B).59 
 
 This study was able to compare 3 different methods used to treat ACL repairs in a 
live model and compare the three with basic parameters to help determine the efficacy of 
a bio-enhanced ACL repair as a superior treatment option compared to no repair. All 
methods were found to be superior to an untreated ACL tear in terms of biomechanical 
performances.  
 The model limits this study as porcines are quadruped and is, therefore, dissimilar 
to the human models with post-op rehab as previously stated along with several other 
limits proposed by the model.  Also the transection was completed using a scapel, which 
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does not create frayed ends as would occur during a more natural mechanism of ACL 
tear.  
 The advantages of this study include a direct-blinded comparison of 3 different 
repair methods in terms of their biomechanical properties, as well as potential long-term 
outcomes specific to development of osteoarthritis, which had not been previously done 
using the bioenhanced ACL repair method. Also, although not ideal, the platelet profile 
and wound healing of the porcine model share a greater resemblance to humans 
compared sheep or goats, along with other anatomically relevant similarities.59 
 
Murray et al 2016 
 In this study twenty patients were enrolled in a non-randomized, first-in-human 
safety study. Patients receiving the bridge enhanced ACL repair (BEAR) technique 
(N=10) were compared to 10 patients receiving autologous hamstring graft reconstruction 
(ACLR). The goal was to ensure the implanted scaffold would not result in deep joint 
infection, while also providing initial evidence of postoperative outcomes within the first 
3 months. Patients aged 18 to 35 years with a complete ACL tear who were less than 1 
month from injury and who had at least 50% of the length of the ACL attached to the 
tibia on their preoperative MRI were eligible to enroll in the study.  
 The numbers of patients who also had a meniscal tear was equal in the two groups 
along with the amount of effusion seen just prior to the operation. The difference in 
Lachman testing was similar in both groups as well and every patient either had a pivot 
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glide or “clunk” during pivo-shift testing once they had general anesthesia. Post-op rehab 
and bracing was identical in both treatment groups. 
 By 3 months the BEAR scaffold was fully resorbed. Therefore, any adverse 
events (infection, inflammation, scarring) or failure to heal due to the scaffold material 
should have been evident or would have occurred by that time. Outcomes at 3 months 
after treatment were tested and graded on terms of post-operative pain, muscle atrophy, 
loss of range motion, and implant failure. No joint infections were noted in either group 
and no difference was found in the two groups when it came to effusions, pain or failures 
by Lachman examination criteria. MRI from both groups showed an intact and 
continuous ACL, while hamstring strength was found to be better in the BEAR group 
compared to those with the hamstring autograft (mean ± SD: 77.9% ± 14.6% vs. 55.9% ± 
7.8% of the contralateral side; P < .001). 42 
 Several limitations can be noted for this study with the main being the small size 
of patients enrolled, as a small sized study was less likely to note adverse effects as well 
as lack of randomization to treatment groups. However, the purpose of this study was to 
evaluate safety for guidance of the FDA for long-term efficacy trials. Also, distinction in 
the outcome between the ACL reconstruction and BEAR groups, which were already 
small to begin with compared to the standard deviations of measurements, would be 
undetectable in this sample size. Additionally, the short-term follow-up time of 3 months 
was not enough to determine the efficacy of the BEAR technique as compared to the 
hamstring tendon autograft. Additional studies utilizing a larger sample size and a longer 
follow-up time are merited. Also, only patients with a maximum of 50% loss of the 
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length of the ACL were included in the study; whether this technique would be effective 
in patients with a greater percentage loss or resorption of ACL tissue is not known. 
 
Murray et al. 2019 
 This follow up paper was completed using the previous 20 patients from Murray 
et al, 2016 were reevaluated to compare outcomes between the BEAR technique and 
ACLR at 6, 12 and 24 months in physical exam findings and function. To determine 
outcome measures, the IKDC subjective score was used to evaluate knee effusion, range 
of motion, and ligament stability via the Lachman and pivot-shift test generating a scaled 
overall grade. (A: normal to D: severely abnormal). The Knee injury and osteoarthritis 
outcome score (KOOS) evaluates 5 features including pain symptoms, ADLs, 
sports/recreation, and knee-related quality of life with a questionnaire that was 
administered pre-op and at the 6, 12, and 24 month intervals.34 
 In contrast to the ACLR group, hamstring strength indices were much better (P = 
.0001) when measured by a handheld dynamometer.  BEAR group patients had a better 
return of strength in contrast to patients of the ACLR group (P = .001 at 6 months, P = 
.006 at 12 months, and P = .0001 at 24 months). Also, the BEAR group patients 
recovered a mean of approximately 90% to 99% strength as compared to their 
contralateral knee, in contrast to only 56% to 64% strength recovery for patients in the 
ACLR group. 
 Arthrometer testing demonstrated mean side-to-side differences in AP laxity that 
were similar in the 2 groups at 24 months (BEAR, 1.94 ± 2.08 mm; ACLR, 3.14 ± 2.66 
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mm). Functional hop testing results were similar in the 2 groups at 12 and 24 months 
after surgery. 
 The IKDC subjective scores in both groups improved significantly from baseline 
to 84.6 ± 17.2 in the ACLR group and to 91.7 ± 11.7 in the BEAR group at 24 months 
(P < .0001). An IKDC objective grade of A (normal) was found in 44% of patients in the 
BEAR group and in 29% of patients in the ACLR group at 24 months; no patients in 
either group had C (abnormal) or D (severely abnormal) grades. Therefore, both groups 
had marked improvement over baseline values for the IKDC subjective score and all 
KOOS subscores. With 1 exception (KOOS Symptoms subscore at 6 months in the 
ACLR group, P = .11), all 5 KOOS subscores also improved significantly from baseline 
in both groups, typically by about 25 to 60 points (all P ≤ .02). 
 The percentage of patients with a normal IKDC grade in the BEAR group was 
50% higher than in the ACLR group (44% vs 29%, respectively). In this study, the IKDC 
subjective score averaged about 85 points in the ACLR group at both the 12- and 24-
month follow-ups, similar to the 24-month scores reported by the Multicenter 
Orthopaedic Outcomes Network (MOON) Group (81 points) after ACLR.34 Patients in 
the BEAR group had a similar mean score at 12 months (∼83 points), with a subsequent 
mean score of approximately 92 points at 24 months after surgery, and similar to that 
previously reported for men and women without knee injuries (∼93 points).34 Thus, 
outcomes were similar to what has been previously reported in larger studies determining 
the efficacy and outcomes of previous ACLR.  
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 One patient in each group (10%) required a subsequent medial meniscal surgery. 
The reported risk of meniscal surgery in the first few years post ACLR has previously 
been reported to range from 4% to 24%, with younger cohorts generally having a higher 
rate. 
 The largest limitation of this study was its small number and the 
nonrandomization of the treatment choice. However, this is usually the protocol to follow 
before performing a larger study when translating a new scaffold into human patients to 
ensure no significant problems arise. Most measurements reported were similar between 
the groups, which would suggest a larger study with greater power is needed to detect 
whether difference between the groups is statistically significant. However, the study was 
able to use previous trials to compare the outcomes of the small cohort within the study 
with larger studies (KANON trial, MOON Group Study) using the same metrics to 
determine effectiveness of treatment.  
 These previous studies have found that there still exist potential in primary repair 
of ACL tears, however it needs the adjuvant of modern technology and biology. With 
years of research we have found the gap impeding an ACL from healing on its own or by 
simple repair. The addition of a collagen platelet scaffold in the BEAR technique helps 
provide the necessary components needed to physiologically resemble this process. A 
stable, soft scaffold bringing the two torn ends into proximity, along with the healing 
factors required to promote healing in a sterile way, may avoid the adverse events seen in 
conventional ACLR. To build off previous research and confirm the preliminary findings, 
a larger study is required to prove that the BEAR technique maintains the lower incidence 
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of adverse events, enables full healing of the torn ACL, and avoids the pain and weakness 






 This study will be a single center randomized controlled trial comparing the novel 
BRIDGE enhanced ACL Repair technique against the hamstring autograft reconstruction 
in patients with a recent Grade 3 ACL tear.  
	
Study population and sampling 
 78 patients will be recruited over 6 months from the outpatient orthopedic clinic 
at Boston Children’s Hospital.  We will make healthcare providers aware of our study 
and technique via national conferences to help with recruitment. With New England 
amassing 25% of the US population we can assume to see 2,000 ACL tears in New 
England in one month based on an incidence of 100,000 to 200,000 ACL ruptures each 
year in the United States. Based on our inclusion/exclusion criteria, the likelihood of 
desire to be in a clinical study, and need to travel we can presume to see about 5% of this 
estimated 2,000 ACL injuries in New England in one month.  
 Inclusion criteria comprises patients between the ages of 14-35 years of age with 
a grade 3 ACL tear that are capable of having one of the treatment techniques within 45 
days of injury. Patients will need to have at least 50% of the ACL still attached to its 
tibial insertion site and will need to have closed physes in order to participate. Only 
patients who stand to benefit from an operation will be considered for the study. Patients 
will be excluded from either group if they have a history of prior surgery on the knee, a 
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history of prior knee infections or have a high risk for adverse affects of healing 
(nicotine/tobacco use, corticosteroids in the past 6 months, chemotherapy, diabetes, 
inflammatory arthritis). Patients will be excluded if they have a displaced buck-handle 
tear of the medial meniscus that requires repair. However, those with all other meniscal 
injuries will be included and treated as part of the study (to allow for a larger sample to 
be accrued over a shorter time). Patients will also be excluded if they have a full-




Allocation and Randomization 
 This is a randomized controlled trial where patients will be placed randomly into 
one of two arms with 39 patients in each study group. The study will consist of 78 
patients undergoing surgery for an acute ACL tear with patients blinded to their treatment 
method and will be unblinded after evaluation at 3 months.  
	
BEAR Scaffold and ACLR Procedure 
 The BEAR scaffold will be manufactured at Boston Children’s Hospital and has 
previously completed all biocompatibility and sterility testing prior to use in clinical 
studies. It is comprised of extracellular matrix proteins, including collagen, that are 
obtained from bovine tissue. The DNA content of the scaffolds is less than 50ng/mg of 
scaffold and the scaffold is not crosslinked. The scaffold measures 22mm in diameter by 
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44 mm in length and is hydrophilic, able to absord up to 5 times its weight in fluid. The 
BEAR scaffold softens when blood is added to it, making it more comfortable in the 
intra-articular notch and able to fill in irregular contours of the gap between the torn 
ligament ends.  
 After induction of general anesthesia, an examination will be performed to verify 
the positive shift test on the injured side and record the Lachman, range of motion, and 
pivot-shift examination results on both knees. Then knee athroscopy will be performed, 
and menisical injuries will be treated, if present. The tibial aimer (ACUFEX Director 
Drill Guide; Smith & Nephew) will be used to place a 2.4-mm guide pin up through the 
tibia in the anterior 25% of the tibial ACL footprint, and the pin will be overdilled with a 
4.5-mm reamer (4.5-mm Endoscopic Drill; Smith & Nephew). A guide pin will be placed 
in the anterior 25% of the femoral ACL footprint, drilled up through the femur, and then 
overdrilled using the 4.5-mm reamer.  A 2-inch arthrotomy will be made at the medial 
border of the patellar tendon and a whipstitch of No. 2 Vicryl will be placed into the tibial 
stump of the torn ACL. Two No.2 Ethibond sutures will be looped through the 2 center 
holes of the cortical button (Endobutton: Smith & Nephew). The No. 2 Vicryl suture 
from the tibial stumps free ends will be passed through the cortical button and the button 
carrying the Ethibond and Vicryl sutures will be passed through the femoral tunnel and 
engaged on the lateral femoral cortex. Both of the looped sutures of the No. 2 Ethibond (4 
matched ends) will be passed through the scaffold and through the tibial tunnel. 
Autologous blood attained from the AC vein (10 mL) will be added to the scaffold. The 
scaffold will then be passed along the sutures into the femoral notch and the Ethibond 
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sutures pulled distally and tied over a second cortical button to the anterior tibial cortex 
with the knee in full extension. The free ends of the No.2 Vicryl suture from the ACL 
whipstitch coming through the femur will then be tightened and tied over the femoral 
cortical button to bring the ACL stump into the scaffold using a arthroscopic surgeon’s 
knot and knot pusher and the arthrotomy will be closed in layers.   
 
ACL Reconstruction with Autologous Hamstring Tendon 
 After induction of general anesthesia, an examination will be performed to verity 
the positive pivot shift on the uninjured side and to record Lachman, range of motion, and 
pivot-shift examination results on both knees. A standard hamstring autograft procedure 
will be performed using a quadruple semitendinosus-gracilis graft looped over 
continuous-loop cortical button (Endobutton) for proximal fixation and bioabsorbable 
interference screw (BioRCHI HA; Smith & Nephew) for tibial fixation. Concomitant 
treatment of meniscal injuries will be performed. 
	
Study variables and measures 
 The primary outcomes are MRI and physical exam confirmation of an intact ACL 
at 3 months, evidence of any adverse events post-op (as described below) and hip 
abduction strength, hamstring strength and IKDC scoring data. We will also include 
duration on crutches and time to return to sport.  Demographic variables will consist of 
patient age, sex, height, weight, BMI and preoperative level of fitness/activity, as well as 
time to surgery and mechanism of injury. 
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 Review of the electronic medical record of each patient will catalogue co-
morbidities such as diabetes, rheumatoid arthritis, smoking status, osteoarthritis, prior 
operations, obesity, hypertension, depression, etc. 
	
Adverse Reaction 
Deep Joint Infection 
 Patients will self-monitor for signs of possible deep joint infection (fever >101oF, 
increasing pain in the knee, presence of an effusion, drainage from the knee).  If 
symptoms arise, a preset protocol will be in place to perform knee arthrocentesis and, if 
organisms can be cultured from joint fluid, the patient will be classified as having a deep 
joint infection and treated accordingly.  Patients must make provider aware and present to 
clinic in order to assess the knee and determine appropriate course of action. 
Mark Inflammatory Reaction 
 All patients will be monitored for signs of a swollen, warm knee at the 3-month 
follow-up. If a patient presents with a swollen, warm knee and there is clinical suspicion 
of marked inflammation or a septic joint, arthrocentesis will be performed. If synovial 
fluid is negative for organisms, the patient will be classified as having a marked 
inflammatory reaction and treated accordingly. Patients are also able to schedule a 
follow-up prior to the 3-month time period if concerned over potential inflammatory 




 At the 3-month mark, if Lachman examination is performed and deemed grade C 
(abnormal) or grade D (severely abnormal), the implant or graft would be classified as a 
failure and patient will be treated accordingly. The clinical Lachman examination will be 
graded according to International Knee Documentation Committee (IKDC) 
recommendations as grade A (–1- to 2-mm side-to-side difference, firm endpoint), grade 
B (3- to 5-mm side-to-side difference, firm endpoint), grade C (either 3- to 5-mm side-to-
side difference with a soft endpoint or a 6- to 10-mm side-to-side difference with a soft or 
firm endpoint), and grade D (>10-mm side-to-side difference). Knee sleeves will be 
administered to cover both knees to keep the examiner blinded as to the surgical side of 
the study group when performing physical examination.  
	
Outcome Measures 
Magnetic Resonance Imaging  
 MR imaging will be obtained for all operated knees at 3 months. Using a 3-T 
scanner (Tim Trio; Siemens) and a 15-channel knee coil, sequences to be performed on 
the surgical knee are: 3-plane gradient echo localizer, axial and oblique sagittal fast spin 
echo T2 with fat saturation, coronal proton density with fat saturation, and volumetric 3D 
sagittal proton density SPACE with axial and coronal reformations. The region of the 
ACL repair or graft will be assessed for integrity, continuity of fibers from femoral 
attachment/tunnel to tibial attachment/tunnel, as well as surrounding fluid and 
inflammatory change. Implant or graft failure will be classified as the absence of intact, 




Range of Motion 
 Passive and active range of motion will be measured at each postoperative visit 
using a goniometer and recorded for analysis at the 3-month visit. Knee sleeves will be 
used to cover both knees for all patients and the examiner will be blinded to the surgical 
side and study group when performing the physical examination. 
Hamstring strength will be measured with the patient prone and the knee in 90° of 
flexion. The dynamometer is placed on the posterior surface of the lower leg proximal to 
the ankle. The manufacturer claims that either the “make” or “break” techniques can be 
utilized for isometric strength measurements; we will use the “make” technique in our 
study because of previous evidence of its superiority with intertester reliability. 
Quadriceps strength will be measured with the patient in the same position but the 
dynamometer will be placed over the distal tibia. With the patient lying on their side hip 
abductor strength will be measured with the dynamometer at the midlateral thigh.  
 The difference between the surgical and non-surgical knees for passive range of 
motion will be used at the 3-month time point compared to the preoperative measurement 
(taken after the knee had undergone preoperative rehabilitation) and used as the baseline 
grade. The overall range of motion grade will be based on the worst of the extension and 
flexion grades. 
 The Lachman and pivot-shift test will be performed under anesthesia for the 
baseline values and without anesthesia at follow-up. The difference between the surgical 
knee and contralateral knee will be reported for all measures. The overall ligament grade 
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is defined as the worst of the Lachman and pivot-grades. An independent examiner will 
perform each test with knee sleeves covering both knees. The examiner will be blinded to 
the surgical side and study group when performing the physical examinations until the 
end when effusion will be assessed after removal of the sleeve. 
 
IKDC 
 The IKDC Subjective Score will be used per published instructions.60 Knee 
effusion, range of motion, and ligament stability measures (Lachman test and pivot-shift 
test) will be performed at 3 months and results will be recorded individually and then 
combined as specified by the IKDC form (see appendix) to generate an overall grade 
based on the IKDC score (A = normal, B = nearly normal, C = abnormal, D = severely 
abnormal), defined as the worst of the effusion, range of motion, and ligament grades. 
 To measure the anterior displacement of the tibia about the femur under 130 N of 
applied anterior force an arthrometer will be used and performed on each leg. Results will 
be reported in a side-to-side difference by subtracting the mean of the surgical knee from 
the mean of the contralateral knee.  
 The Objective Score from the IKDC index will be calculated for all patients per 
published instructions. Each surgical and non-surgical knee will be evaluated prior to 





 Patients with complete Grade 3 ACL tears who meet the inclusion and exclusion 
criteria will be recruited from the outpatient orthopedic clinic of Boston Children’s 
Hospital. Also, presentations will be given at various conferences and meetings in order 
to make outside providers aware of this trial in order to bolster recruitment. The 
institution will be responsible for generating a list of candidates who plan to receive 
orthopedic care and may require ACL surgery. Candidates will be informed of the study 
by mail one week prior to their appointment in order for them to gain awareness and 
information about the study. At the time of the first initial visit for patients who fit the 
criteria, the investigator will meet with the patient and parent(s) to provide further 
information regarding the trial including risk factors and benefits as well as the potential 
to receive either treatment. Individuals who choose to be enrolled will sign a consent 
form to be registered for the study and those under 18 years of age will require consent 
confirmation from their legal guardian.   
	
Data Analysis and Collection 
 Before treatment is initiated a complete physical exam and medical history will be 
required of each patient either by their Primary Care Physician or by a Physician at 
Boston Children’s Hospital. Imaging will be done at clinic of choice however a specified 
radiologist will complete the readings of the images to determine applicable candidates 
and extent of ACL injury as well as any associated injuries.  A complete knee exam will 
be done on each patient under anesthesia prior to beginning surgery as stated in Range of 
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Motion section above. In terms of questionnaires for the IKDC measurement these will 
be sent via email the day prior to the patients 3-month follow-up appointment for them to 
fill out and complete based on their subjective findings. Measurements at 3 months to be 
collected during follow-up visit as detailed above.  Adverse outcomes will be added to 
the patient case if treatment is required at any point during the study. 
 Demographic data such as gender, ethnicity, age, etc will be analyzed using 
descriptive statistics via patient charts. Baseline comparisons between the ACLR and 
BEAR treatment groups will be done using t tests and Wilcoxon tests for continuous 
variables, while Fisher exact tests will be used for categorical measurements. Changes in 
the baseline IKDC score will be assessed within each group using a chi-squared test. All 
statistic parameters will have a p<0.05 as their limit. 
	
Timeline and Resources 
 The study will begin in the spring of 2020 with the proposal being submitted to 
the IRB with approval taking 2-3 months. Upon approval, 2-3 weeks of coordination will 
begin internally at Boston Children’s Hospital and its outpatient clinic as the staff will be 
informed of the study and presentations will be made regarding the previous study 
performed concerning this technique and its need for a larger sample size comparing 
outcomes. Once recruitment begins the study is expected to run between two to three 
years. Recruitment will require the most time (estimated at 6 months based on 
explanation in study population and variables), however patients will be actively 
enrolled, treated, and examined at the 3-month post-op interval while recruitment is still 
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active. This will allow for fluidity in the process and allow surgery to be completed 
within the 45-day period of injury. Data analysis and independent evaluation of the data 
is expected to take 4-6 months once all patients have received surgery and have 
completed their 3-month follow-up. The total project timeframe of this study is around 14 
to 16 months. 
 Resources required for this study are similar to those in the previous study 
completed at Boston Children’s Hospital. This includes a Magnetic Resonance Imager 
and a radiologist to read them as well as an experience surgical team for both treatment 
arms.  Access to electronic medical records will be necessary to retrieve the clinical and 
demographic data as well as most recent history and physical exam if not completed at 
BCH.  
	
Institutional Review Board 
 Prior to initiation of the study, approval will be obtained from the IRB. The 
Boston University Medical Campus IRB and the corresponding IRBs of the participating 
institutions will submit the protocol of this study for full IRB review. Full IRB approval 
is necessary given the experimental nature of the intervention and the possibility for 
morbidity and mortality to any human subjects enrolled within this trial as well as those 









 The study detailed herein has some limitations. Obstacles include the likely 
exclusion of patients with ACL injuries based on our criteria, loss to follow-up and 
disinterest in being blinded to their repair technique. Also, the short follow up time period 
puts a limitation on true examination of performance of each technique against each other 
as full recovery and return to play is not truly seen in most patients until a full year after 
surgery.  This short follow-up time could underestimate true outcomes as some patients 
may require longer recovery periods depending on extent of injury and their pre-injury 
state in terms of fitness and strength. Only patients with a maximum of 50% loss of the 
length of the ACL were included in the study; whether this technique would be effective 
in patients with a greater percentage loss or resorption of ACL tissue will not be able to 
be ascertained in this study.  Also, by allowing patients with concomitant ligament and 
meniscal injuries into the study we run the risk of these patients being placed into the 
same repair/reconstruction technique, which could affect outcomes for said group.  
 This study will investigate post-op outcomes in patients with the BEAR technique 
to gold standard hamstring technique. Comparing hamstring strength 3-months post-op 
can help determine if the technique decreases donor site morbidity, as well as 
supplementing a shorter recovery period. The large sample size will also allow us to 
identify any potential adverse events that could result from this new technique as 
previous studies had small sample sizes. We will also be able to identify shortcomings in 
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terms of an intact and stable ACL in a larger cohort that would show signs of graft failure 
based on MRI findings and physical exam testing.  This study allows for generalizability 
for the specific cohort of patients who are hoping to have improved outcomes in terms of 
the pediatric and young active population looking for a full return to sports and 
prevention of long-term knee outcomes.    
 This study is completely blinded to patients and testers, which will prevent tester 
bias. Also, a larger sample size gives us the potential to see any adverse events as well as 
potential graft failures. It will also give us statistical power to detect differences in 
outcomes. These patients can also be followed several months to years after surgery as 
with previous studies to determine functional outcomes, return to play, and maintenance 
of an intact ACL.  
	
Summary 
 ACL tears are a common occurrence and can be debilitating and costly when it 
comes to post-op rehabilitation and the potential for re-injury or other orthopedic injuries. 
They can also cause issues with osteoarthritis later in life leading to frequent steroid 
injections for pain reduction, extensive strength training to avoid further injury, and have 
the potential to result in early requirements for knee replacement surgery. Many patients 
who do not gain full recovery from ACL tears will have difficulty returning to play, 
which could result in poor physical activity and increase their chances of obesity leading 
to other health conditions.  While current surgical treatment modalities for ACL tears 
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have shown quality outcomes for patients, the desire for a novel technique that avoids 
using auto- and allografts to maintain innate physiology of the ACL joint is essential.  
 With the BEAR technique the healthy tendons about the knee are not 
compromised to create a graft and, therefore, the BEAR procedure may result in less loss 
of strength in the postoperative period. Also, if the native fibers within the ACL are 
preserved with this method it will likely result in better proprioceptive functioning of the 
joint, which has the potential to preserve the knee from posttraumatic osteoarthritis, as 
observed in previous preclinical studies.  
 Additionally, the BEAR technique does not require exact tissue reapproximation 
as it fills the gap between the torn ligament ends with a biologically active scaffold 
allowing for a near physiologic healing process. 
	
Clinical and/or public health significance 
 Patients who suffer ACL tears are likely to face long rehab periods as well as 
inability to fully return to pre-injury physical states that could compound on their 
physical and mental health.  Most of these injuries occur in high school and college 
athletes who are participating at a high level who may be basing their futures on potential 
scholarships or even professional contracts.  
Arden et al6263 published two systematic reviews and meta-analyses evaluating the rate of 
return to place and associated factors after ACL reconstruction.  Rates of return to any 
sport, at their previous level of competition, and competitive sports were 81% to 82%, 
63% to 65%, and 44% to 55%, respectively. Many patients had fear of reinjury (19%) 
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and functional problems of the reconstructed knee (13%) as the 2 most common reasons 
for not returning to sports.   
 In a study completed in 2019 they reported on the incidence of 
contralateral ACL injuries to be 28% among athletes who returned to sports versus 4% 
among athletes who did not return (P = .017) after early ACLR. The pooled reinjury rate 
after return to preinjury level of sports was 41% (30%, contralateral injuries; 11%, 
revision surgery). And although 83% of patients returned to pivoting sports after early 
ACLR, only 53% returned to preinjury level.64  
Many active young adults rely on sports as a part of their routine to keep them on track 
and focused while others use them as a way to escape and relieve their anxieties. 
Reducing the risk of reinjury is paramount as compounding injuries will likely lead to 
exercise fear and reduction in physical activity.  
 Aside from highly competitive athletes, ACL tears can occur in everyday people 
during their leisure activities. Without the highest quality of care and desire to bear a long 
recovery this population runs the risk of facing future osteoarthritis leading to pain, 
frequent medical appointments to address it with requirement for corticosteroid injections 
and eventual knee replacements earlier than anticipated. 
 One study using a database of patients who underwent ACLR found that after 
fifteen years, the cumulative incidence of knee athroplastly following cruciate ligament 
reconstruction was low (1.4%); however, it was seven times greater than the cumulative 
incidence of knee arthroplasty among matched control patients from the general 
population (0.2%).65 Another study examined cartilage changes on MRI up to 11 years 
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after ACL injury. Early osteoarthritis was observed after operative and nonoperative 
management. ACL-reconstructed knees had more chondral change than the nonsurgical 
knees after 1 year. Also, there is greater risk of cartilage loss in nonsurgical knees 
suffering ACL tears over the long term versus ACL-reconstructed knees meaning 
treatment of a torn ACL is important for prevention of OA.66 
 A study found a total of 81979 knee replacements done in 2010, this represents an 
increase of 5.7% when compared with 2009 with the cause of this increase being 
unknown. The revision burden was found to be just over 6% of patients requiring 
revision in 2010 with 97% of these knee replacements being the result of osteoarthritis. 
Of course not all of these cases are due to previous ACL injuries but they do contribute to 
this number with most of the population being younger in age resulting earlier treatment 
and the potential for bilateral knee replacements. 67 This paper also reported a total of 
632,000 hospital admissions for knee related arthritis in 2004 with an annual cost of knee 
replacements reaching $22.6 billion dollars thus showing the financial burden OA has on 
the health care community.  
 Patients with OA suffer from serious pain just related to walking and due to this 
they may end up suffering from their loss of cardiovascular exercise causing potential 
weight gain and obesity leading to even more mental and physical health issues. A study 
found that knee-related quality of life is impaired 5–25 years following ACL rupture in 
ACL-deficient individuals compared to population norms, and to an even greater degree 
when compared to young, active adults.68 By further exploring the BEAR technique and 
its ability to maintain innate functionality of the ACL we could eliminate these potential 
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physical and mental health issues.  The economic impact this could have in the short and 
long term could be extensive. The BEAR technique has the potential to shorten 
rehabilitation requirements due to donor site pain and muscle loss as well as preventing 
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